In a volatile fourth quarter, the Wasatch Ultra Growth Fund—Investor Class returned 0.94% and slightly underperformed the benchmark Russell 2000® Growth Index, which rose 1.70%.

Also: cheap Excel and Office training available, an AI startup challenges Intuit and Xero and reasons why Manus is over-hyped ...

Australian-born Harvard geneticist David Sinclair says reversing the symptoms of ageing in animals and humans is now possible ...

The stock market is a dynamic landscape constantly shaped by economic trends, technological advancements, and shifting ...

AI researchers are celebrating a medical breakthrough: a new AI algorithm developed by a team of US researchers can detect ...

We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...

This is Segwise’s second major AI-powered solution, following its widely recognised AI-powered Campaign Monitoring and Alerting Agent.

The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...

Mainz Biomed Enters into Exclusive Licensing Agreement for the Portfolio of mRNA Biomarkers, with Continued Development of ...

Apple's (AAPL) artificial intelligence efforts are in trouble. The company, which debuted its Apple Intelligence platform during its WWDC developer conference last year, was banking on the software to ...

The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...